News
- Statement by WHO's Regional Director on maintaining routine influenza surveillance during the COVID-19 pandemic
- Maldives, Sri Lanka eliminate measles and rubella, ahead of 2023 target
- As more go hungry and malnutrition persists, achieving Zero Hunger by 2030 in doubt, UN report warns
- Lack of regulation leaves door open to harmful digital marketing of alcohol
- Australia's first COVID treatment approved
- Ancient diseases The trace of suffering, in the bones
- EMA finalises opinion on presence of nitrosamines in medicines
- International regulators align positions on phase 3 COVID-19 vaccine trials
- Study estimates more than one million Indians died from snakebite envenoming over past two decades
- FDA Approves New Therapy for Myelodysplastic Syndromes (MDS) That Can Be Taken at Home
- NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools
- HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration Projects
- FDA Authorizes Marketing of IQOS Tobacco Heating System with ‘Reduced Exposure’ Information
- HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment
- WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls
- Launch of public consultation on joint network strategy to 2025
- WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
- Coronavirus (COVID-19) Update: FDA Authorizes Additional COVID-19 Combination Diagnostic Test Ahead of Flu Season
- NIH ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development
- International regulators provide guiding principles for COVID-19 clinical trials
- Coronavirus and pregnancy – preserving maternal health across the European Region
- Joining forces to manage the ‘infodemic’
- New WHO report on alcohol pricing: Europe ignores cost-effective ways to lower health risks
- FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer
- WHO/Europe, EU deliver critical supplies to COVID-19 frontline
Clinical Research News
Aankomende klinische onderzoeken
-
Magnus MedicalCongressionally Directed Medical Research ProgramsWerving
-
Nicholas ButowskiSiren BiotechnologyNog niet aan het wervenGlioom | Hersenen neoplasma | Terugkerende hooggradige gliomenVerenigde Staten
-
State University of New York at BuffaloNog niet aan het wervenBetrokkenheid van de patiëntVerenigde Staten
-
Poitiers University HospitalNog niet aan het werven
-
Assistance Publique - Hôpitaux de ParisNog niet aan het wervenSikkelcelziekte | Vaso-occlusieve crisis
-
University of California, IrvineWervingHersenkanker | Kanker van het CZS | Kanker van het zenuwstelsel | Hersenkanker UitgezaaidVerenigde Staten
-
Qualia Life SciencesWerving
-
Guangdong Raynovent Biotech Co., LtdNog niet aan het wervenFundamentele wetenschap
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationWervingVolwassenen | Digitale assistentie voor slechtzienden | Visuele beperkingenHongkong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Nog niet aan het wervenDuctaal adenocarcinoom van de alvleesklier (PDAC)
-
Sun Yat-sen UniversityNog niet aan het wervenStoppen met roken | AI-agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNog niet aan het werven
